NCT05756257

Brief Summary

The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are:

  1. 1.To determine the association of BPV with functional/cognitive outcome after ischemic stroke.
  2. 2.To determine a pathophysiologic mechanism of BPV's deleterious effect on functional outcome.
  3. 3.To evaluate potential treatment targets to pharmacologically reduce BPV after ischemic stroke.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 6, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

July 15, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

1.7 years

First QC Date

February 15, 2023

Last Update Submit

June 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Functional outcome

    Modified Rankin Scale, the scale uses a range of 0-6 where higher scores indicate decreased function.

    90 days and 1 Year

  • Imaging outcome

    Final infarct volume on MRI at 72 hours

    72 hours +/- 60 hours

Secondary Outcomes (9)

  • Incidence of stroke

    90 days

  • Incidence of stroke

    1 year

  • Change in Montreal Cognitive Assessment scale (MoCA-BLIND) to assess post-stroke cognition

    3 days and 1 year

  • Change in Oral Trails A and B Test to assess post-stroke cognition

    3 days and 1 year

  • Change in Category Fluency tests to assess post-stroke cognition

    3 days and 1 year

  • +4 more secondary outcomes

Study Arms (1)

Acute Ischemic Stroke

Blood pressure variability will be measured in the patients with acute ischemic stroke.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with acute ischemic stroke serve as the source population for the study and will be identified as inpatients at participating centers.

You may qualify if:

  • Ischemic stroke according to the American Heart Association (AHA) definition and either:
  • CT or MRI showing ischemic stroke in the anterior circulation (frontal, parietal or superior temporal lobes), or
  • Occlusion of the internal carotid, middle cerebral or anterior cerebral arteries on computed tomography angiography (CTA) or magnetic resonance angiography (MRA)
  • Onset of ischemic stroke within 48 hours and able to get baseline pMRI within 72 hours of arrival
  • \) NIH Stroke Scale ≥ 4 at time of enrollment

You may not qualify if:

  • Pre-morbid mRS ≥3
  • Predicted hospital system admission \<72 hours
  • Pacemaker or other MRI contraindications per American College of Radiology guidelines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Yale-New Haven Hospital

New Haven, Connecticut, 06510, United States

RECRUITING

University of Chicago Medical Center

Chicago, Illinois, 60637, United States

RECRUITING

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

RECRUITING

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Adam de Havenon, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Adam de Havenon, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2023

First Posted

March 6, 2023

Study Start

July 15, 2024

Primary Completion

March 30, 2026

Study Completion

March 30, 2026

Last Updated

July 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations